On your diagnostic report, there may be an indication of “lesion length”. Does it relate to early or late stage of disease? Does it have anything to do with the choice of treatment?
First, the staging of esophageal cancer is not related to the length of the lesion, not the longer the lesion, the more advanced the staging. The staging of esophageal cancer is mainly based on the infiltration depth of the primary lesion, the metastasis of regional lymph nodes, and the presence of distant metastasis.
The esophagus can be histologically divided into: mucosal layer, submucosal layer, muscular layer, and epithelium. Early-stage esophageal cancer is confined to the mucosa or submucosa, without involvement of the muscularis, and regardless of the presence of lymph node metastases.
But in general, lesion length and depth of lesion infiltration are correlated, meaning that longer lesions usually also infiltrate more deeply.
Second, treatment decisions for esophageal cancer need to consider multiple aspects such as your tumor stage, general condition, and the relationship between the tumor and the large blood vessels, and are not necessarily related to the length of the lesion alone. However, as mentioned earlier, longer lesions will also generally infiltrate deeper; moreover, excessively long lesions will have some impact on surgery, especially the occurrence of postoperative complications, such as anastomotic fistula. Therefore, the length of the lesion is also referred to some extent by the surgeon when making treatment decisions.